Unraveling Alveolar Fibroblast and Activated Myofibroblast Heterogeneity and Differentiation Trajectories During Lung Fibrosis Development and Resolution in Young and Old Mice
Aging Cell · 2025-05 · 24 (5)
DOI: 10.1111/acel.14503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 13.02.2025. Verfasst von Arun Lingampally und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou,…. Hauptthemen laut MEDLINE: Myofibroblasts, Cell Differentiation, Fibroblasts, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, National Natural Science Foundation of China.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is an age‐associated disease characterized by the irreversible accumulation of excessive extracellular matrix components by activated myofibroblasts (aMYFs). Following bleomycin administration in young mice, fibrosis formation associated with efficient resolution takes place limiting the clinical relevance of this model for IPF. In this study, we used aged mice in combination with bleomycin administration to trigger enhanced fibrosis formation and delayed resolution as a more relevant model for IPF. Alveolosphere assays were carried out to compare the alveolar resident mesenchymal niche activity for AT2 stem cells in young versus old mice. Lineage tracing of the Acta2+ aMYFs in old mice exposed to bleomycin followed by scRNAseq of the lineage‐traced cells isolated during fibrosis formation and resolution was performed to delineate the heterogeneity of aMYFs during fibrosis formation and their fate during resolution. Integration of previously published similar scRNAseq results using young mice was carried out. Our results show that alveolar resident mesenchymal cells from old mice display decreased supporting activity for AT2 stem cells. Our findings suggest that the cellular and molecular mechanisms underlying the aMYFs formation and differentiation towards the Lipofibroblast phenotype are mostly conserved between young and old mice. In addition to persistent fibrotic signaling in aMYF from old mice during resolution, we also identified differences linked to interleukin signaling in old versus young alveolar fibroblast populations before and during bleomycin injury. Importantly, our work confirms the relevance of a subcluster of aMYFs in old mice that is potentially relevant for future management of IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou, Zhejiang, China.
- Department of Medicine II, Internal Medicine, Pulmonary and Critical Care, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig University Giessen, Giessen, Germa…
- Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig University Giessen, G…
- Cardio-Pulmonary Institute (CPI), Giessen, Germany.
- Institute for Lung Health (ILH), Giessen, Germany.
- UMR CNRS 7275 Inserm 1323, IPMC, FHU-OncoAge, IHU, RespiERA, Sophia Antipolis, Université Côte d'Azur, Valbonne, France.
ORCID-Profile: Hector A Cabrera-Fuentes, Saverio Bellusci
Förderung
- Deutsche Forschungsgemeinschaft
- National Natural Science Foundation of China
Zitieren
APA
Lingampally, A., Truchi, M., Shi, X., Zhou, Y., Vasquez-Pacheco, E., Panagiotidis, G. D., Hadzic, S., Koepke, J., Vazquez-Armendariz, A. I., Herold, S., Samakovlis, C., Cabrera-Fuentes, H. A., Chu, X., Seeger, W., Zhang, J. S., El Agha, E., Mari, B., Bellusci, S., & Chen, C. (2025). Unraveling Alveolar Fibroblast and Activated Myofibroblast Heterogeneity and Differentiation Trajectories During Lung Fibrosis Development and Resolution in Young and Old Mice. Aging Cell, 24(5). https://doi.org/10.1111/acel.14503
Vancouver
Lingampally A, Truchi M, Shi X, Zhou Y, Vasquez-Pacheco E, Panagiotidis GD, et al. Unraveling Alveolar Fibroblast and Activated Myofibroblast Heterogeneity and Differentiation Trajectories During Lung Fibrosis Development and Resolution in Young and Old Mice. Aging Cell. 2025;24(5). doi:10.1111/acel.14503
BibTeX
@article{Lingampally2025,
author = {Lingampally, Arun and Truchi, Marin and Shi, Xianrong and Zhou, Yuqing and Vasquez-Pacheco, Esmeralda and Panagiotidis, Georgios-Dimitrios and Hadzic, Stefan and Koepke, Janine and Vazquez-Armendariz, Ana Ivonne and Herold, Susanne and Samakovlis, Christos and Cabrera-Fuentes, Hector A and Chu, Xuran and Seeger, Werner and Zhang, Jin-San and El Agha, Elie and Mari, Bernard and Bellusci, Saverio and Chen, Chengshui},
title = {Unraveling Alveolar Fibroblast and Activated Myofibroblast Heterogeneity and Differentiation Trajectories During Lung Fibrosis Development and Resolution in Young and Old Mice},
journal = {Aging Cell},
year = {2025},
volume = {24},
number = {5},
doi = {10.1111/acel.14503}
}
EUVIMED